Cancer Letters

Cancer Letters

Volume 235, Issue 2, 28 April 2006, Pages 239-247
Cancer Letters

Detection of caspase-3 activation in single cells by fluorescence resonance energy transfer during photodynamic therapy induced apoptosis

https://doi.org/10.1016/j.canlet.2005.04.036Get rights and content

Abstract

In many apoptosis pathways, activation of caspase-3 is considered the final stage. In this study, we studied PDT induced caspase-3 activation with fluorescence resonance energy transfer (FRET) technique. A recombinant caspase-3 substrate, SCAT3, was used as the FRET probe. FRET fluorescence images were collected after PDT or TNF-α induced apoptosis. By analyzing the dynamic changes of FRET fluorescence, the results indicate that the caspase-3 activation started immediately after the PDT treatment. In contrast, FRET disruption caused by caspase-3 activation started at 3 h after TNF-α treatment, due to different signaling pathway. The results have proofed, for the first time, that FRET is a sensitive technique that can be used to investigate PDT-induced activation of caspase-3 in real-time and in single cells. By choosing appropriate recombinant substrates as FRET probes, it is likely that FRET technique will provide a new real-time means to study the mechanism of PDT at single cell level.

Introduction

Photodynamic therapy (PDT) is a new cancer treatment modality. Certain photosensitizing drugs can accumulate preferentially in lipophilic cell organelles, including mitochondria, endoplasmic reticulum, nucleus, and lysosomal membranes. The drug accumulated in the target tissue is activated by light of appropriate wavelengths [1], [2], [3]. Light activation of the drug induces formation of reactive oxygen species (ROS). The intermediates are capable to produce cellular damages that ultimately lead to cell death by either necrosis [4], [5], [6], [7], or, apoptosis [8], [9], [10], [11], [12], [13], [14], [15]. The production of ROS by PDT may also promote tissue destruction in part by vascular occlusion leading to ischemic necrosis [16].

Apoptosis is a very important cellular event that plays a key role in pathogeny and therapy of many diseases [17], [18]. The mechanisms of the initiation and regulation of apoptosis are complex and diverse [19]. In many apoptosis pathways, activation of the effector caspases is considered the final step [20]. Among the spectrum of various caspases, caspase-3 is believed to be the primary executioner of apoptosis. With inhibition of caspase-3 activation, cell apoptosis can be blocked [21]. When caspase-3 is activated, depending on the activation mechanism, it can induce chromatin condensation, DNA fragmentation, and cleavage of the DNA repair enzyme poly (ADP-ribose) polymerase (PARP) [22]. Because the caspases-3 activation is a landmark event in apoptosis, assaying caspases-3 has been widely used as a tool for detecting programmed cell death [23]. Caspase-3 activation is typically studied by western blotting or caspase-3 activation detection kits [24], [25]. Unfortunately, these techniques are time consuming and cannot be used to monitor the activation of caspases in real-time. Furthermore, the conventional detection techniques cannot be used to investigate the caspase-3 activation at single cell level.

The fluorescence resonance energy transfer (FRET) is a process by which transfer of energy occurs from a donor fluorophore molecule to an acceptor fluorophore molecule in close proximity. The emission spectrum of the donor molecule overlaps with the absorption spectrum of the acceptor molecule. When the two fluorophores are spatially close enough there is energy transfer between the donor and acceptor molecules. The excited donor transfers its energy to the acceptor. This results in a reduction in donor fluorescence emission and, at the same time, an increase in acceptor fluorescence emission [26]. FRET technique has been used widely to study protein–protein interaction in living cells [26], [27], [28]. Miura et al. [29] has constructed a FRET probe, SCAT3 that consists of a donor (enhanced cyan fluorescent protein, ECFP) and an acceptor (Venus, a mutant of yellow fluorescent protein). The linking sequence contains a caspase-3 cleavage, DEVD [30]. The activation of caspase-3 leads to the cleavage of the linker, thus, effectively reduces the FRET. Using FRET technique based on SCAT3, the spatial-temporal dynamics of caspase-3 activity in individual living cells can be monitored in real-time [29].

PDT induced caspase-3 activation has been reported by Grancille et al. [31] with conventional western blotting technique. In this work, we used SCAT3 as a FRET probe to study the caspase-3 activation in SCAT3-expressing human lung adenocarcinoma cell line (ASTC-a-1) during photosensitization-induced apoptosis. The objective of the study was to further the investigation of PDT induced caspase-3 activation in real-time, using FRET technique, within single cells.

Section snippets

Cell line

The human lung adenocarcinoma cell line (ASTC-a-1) was obtained from Department of Medicine, Jinan University and cultured in RM1640 supplemented with 10% fetal calf serum (FCS), penicillin (100 units/ml), and streptomycin (100 μg/ml) in 5% CO2, 95% air at 37 °C in humidified incubator.

For the FRET experiments, ASTC-a-1 cells were transfected with 1 μg plasmid DNA of SCAT3 and 10 μl of Lipofectin reagent (GIBCO) per 100 μl of serum-free medium at 37 °C for 8 h. The cells stably expressing SCAT3

Intracellular distribution and FRET efficiency of SCAT3

In order to detect the intracellular distribution of SCAT3 in the stably transfected ASTC-a-1 cells, the fluorescence of SCAT3 was collected by a confocal microscope. Venus fluorescence was observed in both cytoplasm and nucleus (Fig. 1). Venus fluorescence was more intense in nucleus than in cytoplasm, likely a result of higher expression of SCAT3 in nucleus. It has been reported that procaspase-3 localizes in the cytoplasm, caspase-3 activation is initiated firstly in the cytosol and the

Discussion

The present report demonstrates that FRET technique can be used monitor caspase-3 activation at single cell level in real-time. Caspase-3 is activated during PDT induced apoptosis that is confirmed by secondary techniques, i.e. Hoechst 33342 staining.

Photodynamic therapy employs a combination of a photosensitizing chemical and visible light to produce singlet oxygen and other ROS [30], [32], and these ROS can cause mitochondrial damage and induce apoptosis through release of cytochrome c and

Acknowledgements

We thank Dr Masayuki Miura of RIKEN Brain Science Institute for generously providing the SCAT3 used in the experiments; Ying Jin and Jinjun Wang for technical assistance.

This research is supported by the National Natural Science Foundation of China (60378043; 30470494), and the Natural Science Foundation of Guangdong Province (015012; 04010394)

References (47)

  • B.A. Pollok

    Using GFP in FRET-based applications

    Trends Cell Biol.

    (1999)
  • D.J. Granville et al.

    Nuclear factor-κB avtivation by photochemotherapeutic agent verteporin

    Immunobiology

    (2000)
  • R.U. Jänicke et al.

    Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

    J. Biol. Chem.

    (1998)
  • J.M. Chandler et al.

    Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver

    J. Biol. Chem.

    (1998)
  • M.P. Boldin et al.

    Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death

    Cell

    (1996)
  • A. Miyawaki et al.

    Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of green fluorescent protein

    Methods Enzymol.

    (2000)
  • T.J. Dougherty et al.

    Photodynamic therapy: review

    J. Natl Cancer Inst.

    (1998)
  • I.J. Macdonald et al.

    Basic principles of photodynamictherapy

    J. Porphyrins Phthalocyanines

    (2001)
  • H.I. Pass

    Photodynamic therapy in oncology: mechanisms and clinical use

    J. Natl Cancer Inst.

    (1993)
  • H. Kato et al.

    Photodynamic therapy for early stage bronchogenic carcinoma

    J. Clin. Laser Med. Surg.

    (1996)
  • M.L. Agarwal et al.

    Photodynamic therapy induces rapid cell death by apoptosis in L5278Y mouse lymphoma cells

    Cancer Res.

    (1991)
  • M. Geze et al.

    Apoptosis during photodynamic therapy—induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence

    J. Photochem. Photobiol.

    (1993)
  • M.L. Agarwal et al.

    Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells

    Cancer Res.

    (1993)
  • Cited by (0)

    View full text